NASDAQ:AMLX | Operating Income | Amylyx Pharmaceuticals, Inc.

Complete source-backed operating income history.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$45.69M
2026-03-31-$43.78M
2025-12-31-$36.61M
2025-09-30-$36.03M
2025-06-30-$42.86M
2025-03-31-$37.8M
2024-12-31-$40.65M
2024-09-30-$75.66M
2024-06-30-$76.29M
2024-03-31-$122.13M
2023-12-31$1.93M
2023-09-30$18.72M
2023-06-30$20.2M
2023-03-31-$2.05M
2022-12-31-$44.59M
2022-09-30-$54.68M
2022-06-30-$54.25M
2022-03-31-$47.81M
2021-12-31-$28.32M
2021-09-30-$22.92M
2021-06-30-$18.59M
2021-03-31-$12.87M

Annual Operating Income

DateOperating Income
2025-12-31-$153.29M
2024-12-31-$314.73M
2023-12-31$38.8M
2022-12-31-$201.34M
2021-12-31-$82.69M